HALO logo
halo search icon
Ensysce Biosciences, Inc.

US$0.32

Price Change Indicator
0.013 (4.23%)
Ensysce Biosciences, Inc.
ENSC · NAS

Ensysce Biosciences, Inc.

Start Trading ENSC for Free

US$0.32

Price Arrow0.013 (4.23%)
21/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Consensus ValueHammer BullishRecent Earnings upgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Ensysce Biosciences, Inc. Overview

ENSC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Weak

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ENSC

icon

Website

Ensysce Biosciences, Inc.

icon

Telephone

1.858.263.4196

icon

Address

Suite 201, 7946 Ivanhoe Avenue, La Jolla, CA 92037

Description

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.

ENSC Price Chart

Key Stats

Market Cap

US$4.56M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.23 - 2.75

Trade Value (12mth)

US$343,701.00

1 week

10.67%

1 month

-28.44%

YTD

-67.02%

1 year

-85.71%

All time high

86364.00

Key Fundamentals

EPS 3 yr Growth

-99.80%

EBITDA Margin

-202.00%

Operating Cashflow

-$8m

Free Cash Flow Return

-225.50%

ROIC

-294.00%

Interest Coverage

-545.30

Quick Ratio

1.60

Other Data

Shares Outstanding (Fully Diluted)

7m

HALO Sector

Healthcare

Next Company Report Date

01-Apr-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ENSC Announcements

Latest Announcements

DateAnnouncements
16 May 26
16 May 26
16 May 26
16 May 26
14 May 26

ENSC Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-70.4-11.45-3.98locklocklock
EPS (Fully Diluted)
 $locklocklocklock-70.4-11.45-3.98locklocklock
Growth
 %locklocklocklock96.683.765.2locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Ensysce Biosciences, Inc. (ENSC:NAS)?
Halo FAQ
The current share price of Ensysce Biosciences, Inc. (ENSC:NAS) is USD$0.32.
What is the 52-week high share price for Ensysce Biosciences, Inc. (ENSC:NAS)?
Halo FAQ
The 52-week high share price for Ensysce Biosciences, Inc. (ENSC:NAS) is USD$2.75.
What is the 52-week low share price for Ensysce Biosciences, Inc. (ENSC:NAS)?
Halo FAQ
The 52-week low share price for Ensysce Biosciences, Inc. (ENSC:NAS) is USD$0.23.
What is the dividend yield for Ensysce Biosciences, Inc. (ENSC:NAS)?
Halo FAQ
Ensysce Biosciences, Inc. (ENSC:NAS) does not pay a dividend.
What was Ensysce Biosciences, Inc. (ENSC:NAS) last dividend payment?
Halo FAQ
Ensysce Biosciences, Inc. (ENSC:NAS) does not pay a dividend.
What is the franking level for Ensysce Biosciences, Inc. (ENSC:NAS)?
Halo FAQ
Ensysce Biosciences, Inc. (ENSC:NAS) has a franking level of 0.00%.
In which sector is Ensysce Biosciences, Inc. (ENSC:NAS) classified?
Halo FAQ
Ensysce Biosciences, Inc. (ENSC:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial